Results 81 to 90 of about 2,542 (110)

Feasibility of <i>TP53</i>-Mutated ctDNA Monitoring in High-Grade Endometrial Cancer Using Routine NGS. [PDF]

Cancers (Basel)
Marlin R, Jean-Laurent M, Joachim C, Vallard A, Pennont S, Suez-Panama V, Rose M, Ulric-Gervaise S, Lusbec S, Bera O, Aline-Fardin A, Ebring C.   +11 more
europepmc   +1 more source

Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma. [PDF]

N Engl J Med
Perrot A, Lambert J, Hulin C, Pieragostini A, Karlin L, Arnulf B, Rey P, Garderet L, Macro M, Escoffre-Barbe M, Gay J, Chalopin T, Gounot R, Schiano JM, Mohty M, Leleu X, Manier S, Mariette C, Chaleteix C, Braun T, De Prijck B, Avet-Loiseau H, Mary JY, Corre J, Moreau P, Touzeau C, MIDAS Study Group.   +26 more
europepmc   +1 more source

A novel RHCE*cE689C allele (p.Ser230Thr) in 2 donors of European ancestry with discrepant E antigen typing. [PDF]

Transfusion
Neto Braga G, Tournamille C, Le Maréchal C, Flahaut R, Ricard C, Floch A.   +5 more
europepmc   +1 more source

Improving Advanced-Line Multiple Myeloma Care: Insights and Real-World Challenges from the EMMY Study. [PDF]

Clin Hematol Int
Cazaubiel T, Decaux O, Royer B, Caillot D, Bobin A, Belhadj-Merzoug K, Macro M, Vincent L, Perrot A, Mohty M, Karlin L, Jacquet C, Frenzel L, Chalopin T, Sonntag C, Fontan J, Rigaudeau S, Touzeau C, Demarquette H, Chaib A, Santana C, Darre S, Bareau B, Garlantézec R, Hulin C.   +24 more
europepmc   +1 more source

Antibody response to tetanus, diphtheria, poliomyelitis, hepatitis B, and H. influenzae b vaccines in allogeneic hematopoietic stem cell transplant adult recipients: A multicenter trial. [PDF]

PLoS One
Epaulard O, Carré M, Hermet E, Corbin V, Tavernier E, Botelho-Nevers E, Daguindau E, Brunel AS, Rohrlich PS, Risso K, Gallet S, Gonnet N, Touati S, Manceau M, Thiebault A.   +14 more
europepmc   +1 more source

Myelodysplastic syndrome with cryptic 5q deletions in young male patients showing sustained response to lenalidomide. [PDF]

Haematologica
Najar W, Barette L, Penther D, Maarek O, Stamatoullas A, Penichoux J, Veresezan EL, Daliphard S, Buchonnet G, Bobee V, Jardin F, De Botton S, Fenaux P, Camus V.   +13 more
europepmc   +1 more source

A molecular signature predicts hematologic evolution in polycythemia vera patients. [PDF]

Leukemia
Mansier O, Lippert E, Benajiba L, Ranta D, Girodon F, Ianotto JC, Chauveau A, Roy L, Boyer F, Médiavilla C, Tavitian S, Divoux M, Fanet M, Sloma I, De Mas V, Denis G, Nunes Gomes C, Calmettes C, Barraco F, Huet S, Vacheret F, Mercier M, Parry A, Legros L, Soret-Dulphy J, Argentin J, Sureau L, Verger E, Orvain C, Riou J, Kiladjian JJ, Cassinat B, Ugo V, Luque Paz D, French Intergroup of Myeloproliferative Neoplasms (FIM).   +34 more
europepmc   +1 more source

Correction: Development and validation of the participatory approach questionnaire (<i>PARTAQUE</i>) in cancer teams: a ready-to-use tool for enhancing the quality of work life for caregivers. [PDF]

Front Psychol
Frontiers Production Office.
europepmc   +1 more source

Efficacy and safety of dapsone in adult primary immune thrombocytopenia. [PDF]

Blood Adv
Larue M, Moulis G, Rueter M, Audia S, Comont T, Terriou L, Viallard JF, Viallard JF, Pan-Petesch B, Royer B, Bonnotte B, Galicier L, Lambotte O, Lefrere F, Cheze S, Ebbo M, Duong TA, Boutin E, Languille L, Mahevas M, Godeau B, Canoui-Poitrine F, Michel M.   +22 more
europepmc   +1 more source

Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France. [PDF]

Clin Hematol Int
Olivier D, Garlantezec R, Perrot A, Macro M, Royer B, Belhadj Merzoug K, Vincent L, Chalopin T, Frenzel L, Bobin A, Mohty M, Touzeau C, Zunic P, LE Calloch R, Lachenal F, Roussel M, Richez-Olivier V, Fleury J, Loppinet E, Leduc I, Tiab M, Delaunay J, Gutnecht J, Corm S, Bazin F, McKelvie-Sebileau P, Rollet S, Mouton H, Gibel L, Louni C, Boumendile A, Hulin C.   +31 more
europepmc   +1 more source